Search

Laboratorios Farmaceuticos Rovi SA

Ouvert

SecteurSoins de santé

58.85 -0.84

Résumé

Variation du prix de l'action

24h

Actuel

Min

58.8

Max

60.35

Chiffres clés

By Trading Economics

Revenu

3.9M

27M

Ventes

4.8M

160M

P/E

Moyenne du Secteur

22.664

36.442

BPA

0.423

Rendement du dividende

1.64

Marge bénéficiaire

16.767

Employés

2,188

EBITDA

4.2M

35M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+35.2% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.64%

3.00%

Prochains Résultats

6 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

181M

3B

Ouverture précédente

59.69

Clôture précédente

58.85

Sentiment de l'Actualité

By Acuity

50%

50%

170 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Laboratorios Farmaceuticos Rovi SA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 oct. 2025, 21:10 UTC

Principaux Mouvements du Marché

Kezar Life Sciences Shares Surge After Break with FDA, Restructuring Plan

16 oct. 2025, 19:03 UTC

Acquisitions, Fusions, Rachats

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- 2nd Update

16 oct. 2025, 17:58 UTC

Acquisitions, Fusions, Rachats

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- Update

16 oct. 2025, 17:12 UTC

Résultats

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

16 oct. 2025, 17:12 UTC

Acquisitions, Fusions, Rachats

Canada Signals Limited Concern Over US Government Stakes in Canadian Miners

16 oct. 2025, 16:59 UTC

Acquisitions, Fusions, Rachats

Airbus's Takeover of Spirit AeroSystems Plants Gets French Antitrust Clearance

16 oct. 2025, 23:44 UTC

Market Talk

Gold Climbs Amid Safe-Haven Demand -- Market Talk

16 oct. 2025, 23:42 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Declines -- Market Talk

16 oct. 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

16 oct. 2025, 22:15 UTC

Résultats

China Tower: Results Supported by Higher Contributions From Energy, Smart Tower Business >0788.HK

16 oct. 2025, 22:15 UTC

Résultats

China Tower 9-Mos Rev CNY74.32B Vs. CNY72.45B >0788.HK

16 oct. 2025, 22:15 UTC

Résultats

China Tower 9-Mos Net CNY8.71B Vs. Net CNY8.15B >0788.HK

16 oct. 2025, 22:02 UTC

Market Talk

Global Equities Roundup: Market Talk

16 oct. 2025, 22:02 UTC

Market Talk

Santos Drifts Into 'Oversold Territory' -- Market Talk

16 oct. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 oct. 2025, 20:50 UTC

Market Talk
Résultats

Health Care Roundup: Market Talk

16 oct. 2025, 20:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 oct. 2025, 20:23 UTC

Market Talk

Recession Risks to Push Canada Toward October Rate Cut -- Market Talk

16 oct. 2025, 20:20 UTC

Résultats

These Stocks Moved the Most Today: TSMC, Salesforce, HPE, F5, United Airlines, Travelers, J.B. Hunt, Praxis Precision, and More -- Barrons.com

16 oct. 2025, 20:08 UTC

Acquisitions, Fusions, Rachats

Jack in the Box to Sell Del Taco With Big Markdown. The Stock Plunged. -- Barrons.com

16 oct. 2025, 19:37 UTC

Acquisitions, Fusions, Rachats

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 oct. 2025, 19:26 UTC

Résultats

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 oct. 2025, 19:24 UTC

Market Talk

U.S. Natural Gas Falls on Mild Weather, Ample Storage -- Market Talk

16 oct. 2025, 19:23 UTC

Market Talk

Oil Falls As Oversupply Concerns Outweigh India News -- Market Talk

16 oct. 2025, 19:23 UTC

Résultats

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 oct. 2025, 18:35 UTC

Market Talk
Résultats

Charles Schwab Logs Another Quarter of Record Revenues, Earnings -- Market Talk

16 oct. 2025, 18:31 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 oct. 2025, 18:31 UTC

Market Talk

Global Equities Roundup: Market Talk

16 oct. 2025, 18:31 UTC

Market Talk

Charles Schwab Readies Spot Crypto Trading -- Market Talk

16 oct. 2025, 16:57 UTC

Market Talk

Oil Futures Lose Ground as EIA Reports Crude Stock Build -- Market Talk

Laboratorios Farmaceuticos Rovi SA prévision

Objectif de Prix

By TipRanks

35.2% hausse

Prévisions sur 12 Mois

Moyen 80.85 EUR  35.2%

Haut 90 EUR

Bas 71.7 EUR

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

2

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

51.1 / N/ASupport & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

170 / 371Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
help-icon Live chat